Complications in Prolonged Intraoperative Ischemia Time in Free Flap Breast Reconstruction: A Systematic Review and Meta-Analysis.

Aesthetic plastic surgery 2025 Vol.49(5) p. 1262-1270

Arellano JA, Comerci AJ, Liu HY, Alessandri Bonetti M, Nguyen VT, Parent B, Bailey EA, Moreira AA, Gimbel ML, Egro FM

관련 도메인

Abstract

[BACKGROUND] Autologous tissue transfer is an effective option for breast reconstruction post-mastectomy, with microsurgical techniques continually evolving. However, a comprehensive analysis of the relationship between prolonged ischemia time during free flap-based breast reconstruction and increased postoperative complications is still lacking.

[METHODS] A systematic review and meta-analysis were conducted following PRISMA guidelines. Methodological quality was evaluated using the MINORS criteria. Studies meeting inclusion criteria were analyzed for total complications, complete and partial flap loss, and secondary outcomes. Data heterogeneity and risk ratios were assessed.

[RESULTS] Seventeen studies encompassing 5636 patients and 6884 free flaps were included. The mean age of patients was 49.43 years (95% CI: 48.27-50.60), with a mean BMI of 26.09 (95% CI: 21.97-30.21), and an average post-harvesting free flap ischemia time of 70.35 min (95% CI: 56.71-83.98). These analyses revealed a heightened risk of total complications (RR: 1.99, 95% CI: 1.61-2.46), complete flap loss (RR: 3.15, 95% CI: 1.32-7.52), partial flap loss (RR: 1.91, 95% CI: 0.92-4.00), hematoma (RR: 1.79, 95% CI: 0.96-3.32), and infection (RR: 2.12, 95% CI: 1.32-3.42) in cases with ischemia time exceeding 60 min. Venous complications predominated in free flap failure cases.

[CONCLUSIONS] Effectively managing ischemia time could be crucial in free flap breast reconstruction to potentially reduce postoperative complications. Although there is a correlation between managing ischemia time and reducing postoperative complications, further research is needed to investigate the possible causation behind this relationship.

[LEVEL OF EVIDENCE I] This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors   www.springer.com/00266 .

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 free flap 피판재건술 dict 5
해부 breast 유방 dict 4
시술 flap 피판재건술 dict 3
해부 tissue scispacy 1
해부 flaps scispacy 1
합병증 hematoma 혈종 dict 1
합병증 infection 감염 dict 1
합병증 Flap Breast scispacy 1
약물 [BACKGROUND] scispacy 1
약물 21.97-30.21 scispacy 1
약물 56.71-83.98 scispacy 1
약물 [CONCLUSIONS] scispacy 1
질환 Ischemia C0022116
Ischemia
scispacy 1
질환 Venous complications scispacy 1
기타 patients scispacy 1

MeSH Terms

Humans; Mammaplasty; Free Tissue Flaps; Female; Postoperative Complications; Mastectomy; Risk Assessment; Middle Aged; Time Factors; Treatment Outcome; Graft Survival; Breast Neoplasms

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문